Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

SI-BONE, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SANTA CLARA, CALIF., JULY 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), THE GLOBAL LEADER IN DEVELOPING PROCEDURAL SOLUTIONS TO ADDRESS CLINICAL CHALLENGES ASSOCIATED WITH COMPROMISED BONE, TODAY ANNOUNCED IT WILL REPORT FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2026 AFTER MARKET CLOSE ON MONDAY, AUGUST 3, 2026. MANAGEMENT WILL HOST A CONFERENCE CALL BEGINNING AT 1:30 P.M. PACIFIC TIME / 4:30 P.M. EASTERN TIME

SI-BONE TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 3, 2026

IAN WELLS, FORMER GLOBAL CHIEF FINANCIAL OFFICER OF HOYA VISION CARE, APPOINTED CFO, BRINGING MULTI-BILLION-DOLLAR P&L LEADERSHIP AND CAPITAL-MARKETS DISCIPLINE TOM WEST, WHO LED INTERSECT ENT TO ITS $1.1 BILLION ACQUISITION BY MEDTRONIC AND NALU MEDICAL TO ITS $600 MILLION ACQUISITION BY BOSTON SCIENTIFIC, JOINS AS AN INDEPENDENT BOARD MEMBER APPOINTMENTS BUILD THE FINANCIAL AND GOVERNANCE FOUNDATION FOR VICENTRA'S NEXT PHASE, FOLLOWING THE RECENT SCALE-UP OF COMMERCIAL MANUFACTURING UTRECHT, THE NETHERLANDS, JULY 14, 2026 (GLOBE NEWSWIRE) -- VICENTRA, A EUROPEAN MEDICAL DEVICE COMPANY COMMERCIALIZING THE KALEIDO INSULIN PATCH PUMP SYSTEM, TODAY ANNOUNCED THE APPOINTMENT OF IAN WELLS AS CHIEF FINANCIAL OFFICER, EFFECTIVE JUNE 19, 2026, AND THE ADDITION OF THOMAS A. WEST, A VETERAN U.S. MEDICAL TECHNOLOGY LEADER, TO ITS BOARD OF DIRECTORS AS AN INDEPENDENT DIRECTOR, EFFECTIVE JULY 1, 2026.

VICENTRA APPOINTS IAN WELLS AS CHIEF FINANCIAL OFFICER AND ADDS MEDTECH VETERAN TOM WEST TO ITS BOARD

SANTA CLARA, CALIF., JUNE 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), THE GLOBAL LEADER IN DEVELOPING PROCEDURAL SOLUTIONS TO ADDRESS CLINICAL CHALLENGES ASSOCIATED WITH COMPROMISED BONE, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING 2026 TRUIST SECURITIES MEDTECH CONFERENCE IN BOSTON, MA. MANAGEMENT WILL BE HOSTING A FIRESIDE CHAT ON TUESDAY, JUNE 16, 2026, AT 5:40 A.M. PACIFIC TIME/ 8:40 A.M. EASTERN TIME.

SI-BONE TO PRESENT AT TRUIST SECURITIES 2026 MEDTECH CONFERENCE ON JUNE 16, 2026

DELIVERED ~11% WORLDWIDE REVENUE GROWTH, RECORD PHYSICIAN ENGAGEMENT AND ~440% IMPROVEMENT IN ADJUSTED EBITDA DELIVERED ~11% WORLDWIDE REVENUE GROWTH, RECORD PHYSICIAN ENGAGEMENT AND ~440% IMPROVEMENT IN ADJUSTED EBITDA

SI-BONE, INC. REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER 2026 AND RAISES 2026 GUIDANCE

SANTA CLARA, CALIF., APRIL 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), THE GLOBAL LEADER IN DEVELOPING PROCEDURAL SOLUTIONS TO ADDRESS CLINICAL CHALLENGES ASSOCIATED WITH COMPROMISED BONE, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING 2026 BOFA SECURITIES HEALTHCARE CONFERENCE IN LAS VEGAS, NV. MANAGEMENT WILL BE HOSTING A FIRESIDE CHAT ON TUESDAY, MAY 12, 2026, AT 8:00 A.M. PACIFIC TIME/11:00 A.M. EASTERN TIME.

SI-BONE TO PRESENT AT BOFA SECURITIES 2026 HEALTHCARE CONFERENCE ON MAY 12, 2026

SANTA CLARA, CALIF., APRIL 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), THE GLOBAL LEADER IN DEVELOPING PROCEDURAL SOLUTIONS TO ADDRESS CLINICAL CHALLENGES ASSOCIATED WITH COMPROMISED BONE, TODAY ANNOUNCED IT WILL REPORT FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2026 AFTER MARKET CLOSE ON MONDAY, MAY 11, 2026. MANAGEMENT WILL HOST A CONFERENCE CALL BEGINNING AT 1:30 P.M. PACIFIC TIME / 4:30 P.M. EASTERN TIME

SI-BONE TO REPORT FIRST-QUARTER 2026 FINANCIAL RESULTS ON MAY 11, 2026

ACHIEVES 20% WORLDWIDE REVENUE GROWTH AND POSITIVE ADJUSTED EBITDA FOR FISCAL YEAR 2025GENERATES FREE CASH FLOW IN THE FOURTH QUARTER 2025

SI-BONE, INC. REPORTS RECORD FINANCIAL RESULTS FOR THE FOURTH QUARTER 2025 AND ISSUES 2026 GUIDANCE

SANTA CLARA, CALIF., FEB. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), THE GLOBAL LEADER IN DEVELOPING PROCEDURAL SOLUTIONS TO ADDRESS CLINICAL CHALLENGES ASSOCIATED WITH COMPROMISED BONE, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING TD COWEN 46TH ANNUAL HEALTH CARE CONFERENCE IN BOSTON, MA. MANAGEMENT WILL BE HOSTING A FIRESIDE CHAT ON MONDAY, MARCH 2, 2026, AT 7:30 A.M. PACIFIC TIME/ 10:30 A.M. EASTERN TIME.

SI-BONE TO PRESENT AT TD COWEN 46TH ANNUAL HEALTH CARE CONFERENCE ON MARCH 2, 2026

SANTA CLARA, CALIF., FEB. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), THE GLOBAL LEADER IN DEVELOPING PROCEDURAL SOLUTIONS TO ADDRESS CLINICAL CHALLENGES ASSOCIATED WITH COMPROMISED BONE, TODAY ANNOUNCED IT WILL REPORT FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2025 AFTER MARKET CLOSE ON MONDAY, FEBRUARY 23, 2026.

SI-BONE TO REPORT FOURTH-QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS ON FEBRUARY 23, 2026

FISCAL YEAR 2025 WORLDWIDE REVENUE OF $200.8 TO $200.9 MILLION, REPRESENTING GROWTH OF ~20% FISCAL YEAR 2025 WORLDWIDE REVENUE OF $200.8 TO $200.9 MILLION, REPRESENTING GROWTH OF ~20%

SI-BONE, Inc.

SIBN

Price

Financial Reports

No items found.

Press Releases

SI-BONE, Inc.

SIBN.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

SIBN